FOXO1 and atherosclerosis: As both Tie receptors can be modulated via their extracellular domains that are available in vessel lumen, they provide vascular targets for counteracting inflammation via Foxo1 transcriptional activity, and hopefully eventually for treatment of atherosclerosis.